Valuation: SOL SpA

Market Cap 477.08Cr 556.75Cr 447.03Cr 408.34Cr 770.63Cr 53TCr 778.23Cr 5.27TCr 2.05TCr 27TCr 2.09TCr 2.04TCr 89TCr P/E 2026 *
25.9x
P/E 2027 * 24.1x
Enterprise Value 521.61Cr 608.71Cr 488.75Cr 446.45Cr 842.55Cr 58TCr 850.86Cr 5.77TCr 2.24TCr 29TCr 2.29TCr 2.24TCr 97TCr EV / Sales 2026 *
2.72x
EV / Sales 2027 * 2.52x
Free-Float
40.02%
Yield 2026 *
0.94%
Yield 2027 * 1%
Manager TitleAgeSince
Chief Executive Officer 65 04/09/1990
Chief Executive Officer 68 15/05/1990
Director of Finance/CFO - -
Director TitleAgeSince
Chairman 68 15/05/1990
Director/Board Member 65 04/09/1990
Director/Board Member 67 27/04/1998
Change 5-day change 1-year change 3-year change Capi.($)
0.00%0.00% - - 556.75Cr
-0.58%+1.77%+1.96%+27.68% 22TCr
-0.78%+0.20%+3.29%+5.39% 6.77TCr
-1.23%-14.91%+488.94%+636.21% 1.95TCr
-1.04%-2.19%+3.21%+67.74% 1.54TCr
-2.31%-15.81%+209.20%+235.19% 672.93Cr
+1.91%-1.28%+3.00%+10.80% 580.66Cr
-1.91%-11.18%+52.30%+143.95% 565.06Cr
+2.85%+3.05%+5.46%+115.97% 556.75Cr
-0.80%-0.56%+0.12%+39.03% 359.91Cr
Average -0.39%-4.10%+85.27%+142.44% 3.94TCr
Weighted average by Cap. -0.63%-0.03%+33.79%+65.58%

Financials

2026 *2027 *
Net sales 191.64Cr 223.65Cr 179.57Cr 164.03Cr 309.56Cr 21TCr 312.62Cr 2.12TCr 824.59Cr 11TCr 839.75Cr 821.46Cr 36TCr 205.22Cr 239.49Cr 192.29Cr 175.65Cr 331.48Cr 23TCr 334.75Cr 2.27TCr 882.98Cr 12TCr 899.22Cr 879.63Cr 38TCr
Net income 19Cr 22Cr 18Cr 16Cr 31Cr 2.14TCr 31Cr 212.6Cr 83Cr 1.08TCr 84Cr 82Cr 3.58TCr 21Cr 24Cr 19Cr 18Cr 33Cr 2.29TCr 34Cr 227.89Cr 89Cr 1.16TCr 90Cr 88Cr 3.83TCr
Net Debt 45Cr 52Cr 42Cr 38Cr 72Cr 4.95TCr 73Cr 492.12Cr 191.58Cr 2.5TCr 195.1Cr 190.85Cr 8.28TCr 40Cr 47Cr 37Cr 34Cr 65Cr 4.44TCr 65Cr 441.53Cr 171.89Cr 2.24TCr 175.05Cr 171.23Cr 7.43TCr
Logo SOL SpA
SOL SpA is an Italy-based company primarily engaged in the research, production and distribution of industrial, pure and medicinal gases. It is also involved in the home care medical business. The Company’s product portfolio includes oxygen, nitrogen, hydrogen, argon, sulfur hexafluoride, carbon dioxide, ozone, helium and mixtures of medicinal gases, among others. Through its subsidiaries, the Company is involved in the provision of home care services, such as oxygen therapy, mechanical ventilation, diagnosis and care of obstructive sleep apnea syndrome, artificial nutrition, telemedicine, health assistance, and the prevention and treatment of skin ulcers. Additionally, it is engaged in the supply and management of medical and technological devices for home care. As of December 31, 2011, the Company had a number of subsidiaries, including Airsol BV, Biotechsol Srl, CTS Srl, Energetika ZJ doo, GTH Gaze Industriale SA, Cryolab Srl, GTS Shpk and Hydroenergy Shpk, among others.
Employees
-
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
52.60EUR
Average target price
61.62EUR
Spread / Average Target
+17.16%

Quarterly revenue - Rate of surprise